+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis



Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis



Bmc Psychiatry 17(1): 70



Systemic lupus erythematosus (SLE) patients are at high risk for depression and anxiety. However, the estimated prevalence of these disorders varies substantially between studies. This systematic review aimed to establish pooled prevalence levels of depression and anxiety among adult SLE patients. We systematically reviewed databases including PubMed, Embase, PsycINFO, and the Cochrane database library from their inception to August 2016. Studies presenting data on depression and/or anxiety in adult SLE patients and having a sample size of at least 60 patients were included. A random-effect meta-analysis was conducted on all eligible data. A total of 59 identified studies matched the inclusion criteria, reporting on a total of 10828 adult SLE patients. Thirty five and thirteen methods of defining depression and anxiety were reported, respectively. Meta-analyses revealed that the prevalence of major depression and anxiety were 24% (95% CI, 16%-31%, I2 = 95.2%) and 37% (95% CI, 12%-63%, I2 = 98.3%) according to clinical interviews. Prevalence estimates of depression were 30% (95% CI, 22%-38%, I2 = 91.6%) for the Hospital Anxiety and Depression Scale with thresholds of 8 and 39% (95% CI, 29%-49%, I2 = 88.2%) for the 21-Item Beck Depression Inventory with thresholds of 14, respectively. The main influence on depression prevalence was the publication years of the studies. In addition, the corresponding pooled prevalence was 40% (95% CI, 30%-49%, I2 = 93.0%) for anxiety according to the Hospital Anxiety and Depression Scale with a cutoff of 8 or more. The prevalence of depression and anxiety was high in adult SLE patients. It indicated that rheumatologists should screen for depression and anxiety in their patients, and referred them to mental health providers in order to identify effective strategies for preventing and treating depression and anxiety among adult SLE patients. Current Meta-analysis PROSPERO Registration Number: CRD 42016044125 . Registered 4 August 2016.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 060128156

Download citation: RISBibTeXText

PMID: 28196529

DOI: 10.1186/s12888-017-1234-1


Related references

SAT0446The prevalence of systemic lupus erythematosus in europe: A systematic review and meta-analysis. Annals of the Rheumatic Diseases 71(Suppl 3): 623.1-623, 2013

Prevalence of cervical HPV infection in women with systemic lupus erythematosus: A systematic review and meta-analysis. Autoimmunity Reviews 2018, 2018

Patients with systemic lupus erythematosus have higher prevalence of thyroid autoantibodies: a systematic review and meta-analysis. Plos One 10(4): E0123291, 2016

Depressive and anxiety symptom prevalence in childhood-onset systemic lupus erythematosus: A systematic review. Lupus 28(7): 878-887, 2019

A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clinical Journal of the American Society of Nephrology 5(11): 2060-2068, 2011

Association between Systemic Lupus Erythematosus and Periodontitis: A Systematic Review and Meta-analysis. Frontiers in Immunology 8: 1295, 2017

Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis. Lupus 22(14): 1489-1503, 2014

Associations between TLR polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis. Clinical and Experimental Rheumatology 30(2): 262-265, 2012

Prevalence of hepatitis B virus and hepatitis C virus infection in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Oncotarget 8(60): 102437-102445, 2017

Assessment of subclinical atherosclerosis in systemic lupus erythematosus: A systematic review and meta-analysis. Joint, Bone, Spine 85(2): 155-163, 2017

Thrombocytopenia as a Prognostic Marker for Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis. American Journal of the Medical Sciences 2019, 2019

SAT0389Assessment of Subclinical Atherosclerosis in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Annals of the Rheumatic Diseases 74(Suppl 2): 800.2-800, 2015

Foot and ankle characteristics in systemic lupus erythematosus: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism 2018, 2018

Vaccinations and risk of systemic lupus erythematosus and rheumatoid arthritis: A systematic review and meta-analysis. Autoimmunity Reviews 16(7): 756-765, 2017

Effects of psychological interventions for patients with systemic lupus erythematosus: a systematic review and meta-analysis. Lupus 21(10): 1077-1087, 2013